Sign in

CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843199512
Phone
(214) 612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G Stake Amended Statement of Ownership
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 4 Insider Changes in Ownership
  14. 8-K Event Material agreement · Other events
  15. 424B5 Offering Prospectus
  16. 8-K Event Results of operations · Other events
  17. 424B5 Offering Prospectus
  18. 8-K Event Regulation FD disclosure
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 7 of 21 · 403 filings